DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20205607

A report of seronegative clinically amyopathic dermatomyositis

Milad Heydari-Kamjani, Jessica Forbes, Lailah Issac, Michelle Demory Beckler, Marc M. Kesselman

Abstract


Clinical amyopathic dermatomyositis is a rare idiopathic inflammatory disease within the spectrum of dermatomyositis. This disease entity presents with similar cutaneous findings as dermatomyositis, but the clinical manifestation of myositis is absent. Given the increased risk also associated with clinical amyopathic dermatomyositis, a high index of suspicion is imperative to minimize rheumatologic and dermatologic misdiagnoses. Here we report a case of seronegative CADM in a young female athlete.


Keywords


Dermatomyositis, Amyopathic Dermatomyositis, Autoimmune, Inflammation

Full Text:

PDF

References


Ghazi E, Sontheimer RD, Werth VP. The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. Clin Exp Rheumatol. 2013;31:128.

Reeder MJ, Wetter DA, Li X, Davis M. Incidence of dermato-myositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted county, Minnesota. Dermatol Clin. 2010;146(1):26-30.

Dalakas MC. The molecular and cellular pathology of inflammatory muscle diseases. Curr Opin Pharmacol. 2001;1:300-6.

Callen JP. Cutaneous manifestations of dermatomyositis and their management. Curr Rheumatol Rep. 2010;12:192-7.

Sontheimer RD. Cutaneous features of classic dermatomyositis and amyopathic dermatomyositis. Curr Opin Rheumatol. 1999;11:475-82.

Koler RA, Montemarano A. Dermatomyositis. American Family Physician. 2001;64(9):1565.

Cassius C, Le Buanec H, Bouaziz JD, Amode R. Biomarkers in adult dermatomyositis: tools to help the diagnosis and predict the clinical outcome. J Immunol res. 2019;2019.

Udkoff J, Cohen PR. Amyopathic dermatomyositis: a concise review of clinical manifestations and associated malignancies. Am J Clin Dermatol. 2016;17(5):509-18.

Sato S, Hirakata M, Kuwana M, Suwa A, Inada S, Mimori T et al. Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheumatism. 2005;52(5):1571-6.

Ungprasert P, Bethina NK, Jones CH. Malignancy and idiopathic inflammatory myopathies. North Am j Med Sci. 2013;5(10):569.